Biogen Inc. (BIIB) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning. My name is Cynthia, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen First Quarter twenty twenty six Earnings Call and Business Update. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. Today's conference is being recorded. Thank you. I would now like to turn the conference over to Mr. Tim Power, Head of Investor Relations. Mr. Power, you may begin your conference. Well, thank you, and good morning, and welcome to Biogen's first quarter twenty twenty six earnings call. During this call, we'll make forward looking statements, which involve risks and uncertainties that may cause actual results to differ materially from our forward looking statements. We provide a comprehensive list of risk factors for us in our SEC filings, which we encourage you to review. Our earnings release and other documents related to our results as well as reconciliations between GAAP and non GAAP results discussed on this call can be found in the Investors section of biogen.com. We've also posted the slides to our website that will be used during the call. On today's call, I'm joined by our President and Chief Executive Officer, Chris Vibacker Doctor. Priya Singhal, Head of Development and Robin Kramer, our Chief Financial Officer. Alicia Alaimo, President of North America, will also be joining for the Q and A section of the call. We'll make some opening comments and move to the Q and A section. And to allow us to get through as many questions as possible, we kindly ask that you limit yourself to one question. And I'll now hand the call over to Chris. Thank you, Tim. Good morning, everyone. So we've had a very strong start to the ye...